Research activities

This is an overview of ongoing research projects where the Janus material is being used.
Last updated:

Circulating sex hormone levels and the risk of esophageal adenocarcinoma: a nested case-control study. Principal Investigator: Eivind Ness-Jensen, NTNU HUNT Research Centre  

Biomarkers of human papillomavirus infection and cancer risk within the NCI HPV cancer cohort consortium (HPVC3). Principal Investigator:  Paul Brennan, International Agency for Research on Cancer 

Identification of biomarkers for gallbladder cancer risk prediction- Towards personalized prevention of an orphan disease. Principal Investigator:  Justo Lorenzo Bermejo, University of Heidelberg

Pooled Analysis of Insulin and Insulin-like Growth factor-I and Colorectal Cancer Risk 
Principal Investigator: Marc Gunter, International Agency for Research on Cancer (IARC) 

Small non-coding RNA and bladder cancer
Principal Investigator: Bettina Kulle Andreassen, Cancer Registry of Norway

Effect of multiple freeze-thaw cycles on selected serum components
Principal investigator: Randi E Gislefoss, Cancer Registry of Norway

Identification of Biomarkers for Indolent and Aggressive Prostate Cancer
Principal investigators: Kristin Taskén, Oslo University Hospital and Ian Mills, University of Oslo Principal investigators for the pilot project using samples from the Janus Serumbank: Fahri Saatcioglu, Ian Mills and Bernd Thiede, University of Oslo 

Molecular mechanisms of androgen action and prostate carcinogenesis
Principal investigator: Fahri Saatcioglu, University of Oslo

Pre-diagnostic hormone levels and development of testicular germ cell tumors in the Janus Serum Bank Cohort
Principal investigators: Katherine McGlynn, National Cancer institute, USA and Elisabete Weiderpass Veinie, Cancer Registry of Norway

Development of testicular germ cell tumor - the role of mycotoxins and small noncoding RNAs
Principal investigators: Tom K Grimsrud and Tom Grotmol, Cancer Registry of Norway 

Genome-wide miRNA profiling in prediagnostic samples from Janus Serum Bank for early diagnosis, improved therapy and surveillance of cancer
Principal investigator: Hilde Langseth, Cancer Registry of Norway 

Endogenous hormones and prostate cancer
Principal investigator: Naomi Allen, University of Oxford, UK

Pre-diagnostic allergy and immune-related biomarkers in glioma risk and survival
Principal investigator: Judith Schwartzbaum, Ohio State University, USA and Karolinska Institutet, Sweden

Cohort based studies in Molecular Epidemiology of Brain tumors
Principal investigator: Beatrice Melin, Umeå University, Sweden

miRNA signatures in patients with colon cancer, breast cancer, and lung cancer
Principal investigator: Eckart U Meese, Saarland University Hospital, Germany

Male Breast Cancer Pooling Project
Principal investigator: Louise Brinton, National Cancer Institute, USA

Serum Organochlorine levels and risk of selected cancers
Principal investigator:  Larry Engel, National Cancer Institute and University of North Carolina, USA

Serum Organochlorine Levels and Primary Liver Cancer: a Nested Case-Control Study
Principal investigator:  Larry Engel, National Cancer Institute and University of North Carolina, USA

Serum concentrations of polyhalogenated aromatic hydrocarbon chemicals and risk of thyroid cancer
Principal investigator:  Mary Ward, National Cancer Institute, USA

HPV 16 antibodies in patients with oropharyngeal cancer
Principal investigator: Karen S. Anderson, Arizona State University, USA

A nested case-control study of hormonal risk factors and thyroid cancer in Janus
Principal investigator: Briseis Aschebrook-Kilfoy, The University of Chicago, USA

Anti-Muellerian Hormone (AMH) and Ovarian Cancer Risk
Principal investigators: Nicolas Wentzensen, National Cancer Institute, USA and Elisabete Weiderpass Veinie Cancer Registry of Norway

Polyomavirus infection and lung cancer among non-smokers
Principal investigator: Paolo Boffetta, Ichan School of Medicine at Mount Sinai, 
New York, USA

Immunological markers and risk of non-Hodgkin lymphoma
Principal investigator: Mark Purdue, National Cancer Institute, USA 

Risk factors for cancer in the Janus Serum Bank Cohort
Principal investigator: Hilde Langseth, Cancer Registry of Norway

Immunoprofiling assay to monitor systemic humoral immune response to the infection with the papillomavirus
Principal investigator: Mari Nygård, Cancer Registry of Norway

Vitamin D, obesity and cutaneous malignant melanoma: risk, survival and risk of subsequent cancers.
Principal investigator: Trude E Robsahm, Cancer Registry of Norway

Relationship between serum albumin-adjusted calcium and risk of ovarian cancer among Norwegian women participating in the JANUS serum bank
Principal investigator: Trude E Robsahm, Cancer Registry of Norway

Investigations of DNA- and RNA quality in long-term stored samples in the Janus Serum Bank
Principal investigator: Randi Gislefoss, Cancer Registry of Norway